The private market for antimicrobials: an exploration of two selected mining and frontier areas of Guyana
Author(s)
Type
Journal Article
Abstract
Objective. To identify challenges that may raise pathogens’ resistance to antimicrobial drugs by exploring the
private market for antimicrobials in two selected mining and frontier areas of Guyana.
Methods. The private sector supply was mapped by approaching all authorized pharmacies and informal
outlets, e.g., street vendors and grocery stores, around the two selected towns. Interviews were conducted
with a) sellers on the availability of drugs, expiration dates, prices, and main producers; and b) customers on
purchased drugs, diagnoses, and prescriptions received before purchasing drugs, and intention to complete
the treatment. The information collected was described, and the determinants of the self-reported intention of
customers to complete the whole treatment were identified.
Results. From the perspective of the supply of antimicrobials, essential medicines faced low and insecure
availability, and prescriptions frequently deviated from diagnoses. From the perspective of the demand for
antimicrobials, one-third of purchased antibiotics had a high potential for antimicrobial resistance as per the
World Health Organization AWaRe classification. A high price reduced the self-reported intention to complete
the treatment among those who had a prescription, while buying the medication in a licensed pharmacy
increased such intention.
Conclusions. In Guyana, there persists a need to establish and revise policies addressing both supply and
demand, such as restricting the sale of antimicrobials to licensed pharmacies and upon prescription, improving prescription practices while reducing the financial burden to patients, guaranteeing access to first-line
treatment drugs, and instructing patients on appropriate use of antimicrobials. Revising such policies is an
essential step to contain antimicrobial resistance in the analyzed areas and across Guyana.
private market for antimicrobials in two selected mining and frontier areas of Guyana.
Methods. The private sector supply was mapped by approaching all authorized pharmacies and informal
outlets, e.g., street vendors and grocery stores, around the two selected towns. Interviews were conducted
with a) sellers on the availability of drugs, expiration dates, prices, and main producers; and b) customers on
purchased drugs, diagnoses, and prescriptions received before purchasing drugs, and intention to complete
the treatment. The information collected was described, and the determinants of the self-reported intention of
customers to complete the whole treatment were identified.
Results. From the perspective of the supply of antimicrobials, essential medicines faced low and insecure
availability, and prescriptions frequently deviated from diagnoses. From the perspective of the demand for
antimicrobials, one-third of purchased antibiotics had a high potential for antimicrobial resistance as per the
World Health Organization AWaRe classification. A high price reduced the self-reported intention to complete
the treatment among those who had a prescription, while buying the medication in a licensed pharmacy
increased such intention.
Conclusions. In Guyana, there persists a need to establish and revise policies addressing both supply and
demand, such as restricting the sale of antimicrobials to licensed pharmacies and upon prescription, improving prescription practices while reducing the financial burden to patients, guaranteeing access to first-line
treatment drugs, and instructing patients on appropriate use of antimicrobials. Revising such policies is an
essential step to contain antimicrobial resistance in the analyzed areas and across Guyana.
Date Issued
2024-01-01
Date Acceptance
2024-10-24
Citation
Pan American Journal of Public Health, 2024, 48
ISSN
0030-0632
Publisher
Pan American Health Organization
Journal / Book Title
Pan American Journal of Public Health
Volume
48
Copyright Statement
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. No modifications or commercial use of this article are permitted. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL. Open access logo and text by PLoS, under the Creative Commons Attribution-Share Alike 3.0 Unported license.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/39494446
PII: RPSP.2024.109
Subjects
Drug resistance
drugs
essential
Guyana.
health policy
Life Sciences & Biomedicine
microbial
prescription drug misuse
Public, Environmental & Occupational Health
Science & Technology
Publication Status
Published
Coverage Spatial
United States
Article Number
109
Date Publish Online
2024-10-24